A hot dozen pharmaceutical and biotech companies that have recently received new funding. Good places to look for a job.
All of the following companies have recently received significant injections of cash. Usually a significant receipt of cash translates into new hiring and the purchasing of new equipment. So in your job search, it could be worth your while to check out these different companies to see if they are hiring. If they aren’t today, they may [...]
A new Biotech company, currently forming in “Stealth Mode” is being formed in Eugene, Oregon.
The company, named Cascade ProDrug, will be a spinoff from the University of Oregon.
Two well-known biotech veterans are creating the company. Augie Sick, who was an executive with Life Technologies and Allan Cochrane, an entrepreneur with ties to Pacific Biometrics have recently begun working on the companies launch.
Cascade ProDrug will be attempting to develop safer and more [...]
Life Technologies announces the purchase of BioTrove and subsequent creation of a spinoff, Biocius.
The primary reason for Life Technologies interest in BioTrove appears to have been their OpenArray® platform. It is a high thruput gene expression and genotyping analysis system. It’s based on a flexible array format that allows life science scientists to do more than 3,000 PCR genotyping or qPCR gene expression assays at a time.
Many of [...]
Hot Biotech Companies. New cash means new hiring in the near future!
Following is a listing of companies that have recently received significant large cash payments from such sources as new collaborations or licensing agreements, issuing of new stock, new series rounds of financing or a merger. The reason we include this information on the blog is because any time that a company receives a large sum [...]
Pacific Bioscience and the search for the Holy Grail of the $1,000 Genome–will their Single Molecule Real Time (SMRT) DNA Sequencing platform do the trick?
With all the bad news that has been out over the last year, it’s always a pleasure to write an article about a company that is exciting and doing extremely well. Pacific Biosciences certainly fits that description.
PacBio is an up and coming life sciences capital equipment company, headquartered in Menlo Park, CA. They were founded [...]
Hot companies–orgaizations recently receiving or announcing good news.
Adamas Pharmaceuticals, Inc., of Emeryhville, California, a privately held company, recently announced that they have closed a $40 million Series D round of funding led by Aeris CAPITAL AG and DAG Ventures. Previous investors MDV-Mohr Davidow Ventures and Northgate Capital also participated in the same round.
“Adamas is at an important inflection point with our [...]
Bristol-Myers Squibb Company reports strong earnings growth for second quarter of 2009.
While net sales in Q2 of 2009 vs Q2 of 2008 were only up modestly, net earnings and Earnings Per Share both spiked, as the result of what appears to have been a well-implemented cost control program.
“The excellent results for the second quarter and first six months of the year clearly represent how Bristol-Myers Squibb [...]
Hot companies in biotech for week ending July 10, 2009
Catalyst Biosciences, Inc. of South San Francisco announced the signing of an exclusive worldwide research and license agreement with MedImmune, the global biologics unit of AstraZeneca plc, to develop novel engineered proteases that specifically degrade or modulate two targets, one of which will address inflammatory and autoimmune diseases.
Catalyst will receive undisclosed upfront licensing fees, [...]
Good news received on companies for Week Ending June 19.
AEterna Zentaris Inc. of Quebec City, Canada, a global biopharmaceutical company focused on endocrine therapy and oncology, announced that they have received commitments to purchase US$10 million of units comprised of common shares and common share purchase warrants in a registered direct offering. AEterna Zentaris expects to receive net proceeds of approximately US$9.25 million after [...]
Companies receiving good news during week ending June 12.
Aileron Therapeutics, based in Cambridge, Massachusetts, has had 4 of the world’s biggest drugmakers invest in them. The venture arms of GlaxoSmithKline, Novartis, Roche and Eli Lilly are investing in a $40 million fundraising by Aileron.
It is believed that their synthetically locked, or “stapled”, peptides will be able to target biochemical pathways involved in cell [...]
Email delivery